Israeli health officials on Thursday reported that Pfizer’s COVID-19 vaccine is just 39 percent effective in preventing infections with the more contagious Delta variant, while noting that the vaccine remains highly effective in preventing serious illness and hospitalization, according to reports.
New statistics from Israel’s Health Ministry, released Thursday, indicated that the vaccine jointly developed by Pfizer and BioNTech provided 88 percent protection against hospitalization and 91.4 percent against severe illness, while being just 39 percent effective against the Delta strain, Bloomberg reported.
